東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Molecular authentication of Epimediu...

Sun, Ye.

Linked to FindBook

Google Book

Amazon

博客來

Molecular authentication of Epimedium species and the anti-osteoporosis effect of Herba Epimedii.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Molecular authentication of Epimedium species and the anti-osteoporosis effect of Herba Epimedii./
Author:	Sun, Ye.
Description:	225 p.
Notes:	Source: Dissertation Abstracts International, Volume: 66-07, Section: B, page: 3598.
Contained By:	Dissertation Abstracts International66-07B.
Subject:	Biophysics, Medical. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3182164
ISBN:	0542237415

Molecular authentication of Epimedium species and the anti-osteoporosis effect of Herba Epimedii.
Sun, Ye.

Molecular authentication of Epimedium species and the anti-osteoporosis effect of Herba Epimedii. - 225 p.

Source: Dissertation Abstracts International, Volume: 66-07, Section: B, page: 3598.

Thesis (Ph.D.)--The Chinese University of Hong Kong (People's Republic of China), 2005.

Herba Epimedii, a well-known traditional Chinese medicine, is frequently used for treating senile functional disease and enhancing kidney function. The aerial parts of five Epimedium species, Epimedium brevicornu Maxim., E. sagittatum (Sieb. et Zucc.) Maxim., E. pubescens Maxim., E. wushanense T. S. Ying and E. koreanum Nakai, are listed as source plants of Herba Epimedii in the latest edition of the Chinese Pharmacopoeia.

ISBN: 0542237415Subjects--Topical Terms:

1017681
Biophysics, Medical.

Molecular authentication of Epimedium species and the anti-osteoporosis effect of Herba Epimedii.
LDR:03336nmm 2200313 4500 001 1819222
005 20061004161535.5
008 130610s2005 eng d
020 $a 0542237415
035 $a (UnM)AAI3182164
035 $a AAI3182164
040 $a UnM $c UnM
100 1 $a Sun, Ye. $3 1900511
245 1 0 $a Molecular authentication of Epimedium species and the anti-osteoporosis effect of Herba Epimedii.
300 $a 225 p.
500 $a Source: Dissertation Abstracts International, Volume: 66-07, Section: B, page: 3598.
500 $a Advisers: Kwok-Pui Fung; Pang-Chui Shaw.
502 $a Thesis (Ph.D.)--The Chinese University of Hong Kong (People's Republic of China), 2005.
520 $a Herba Epimedii, a well-known traditional Chinese medicine, is frequently used for treating senile functional disease and enhancing kidney function. The aerial parts of five Epimedium species, Epimedium brevicornu Maxim., E. sagittatum (Sieb. et Zucc.) Maxim., E. pubescens Maxim., E. wushanense T. S. Ying and E. koreanum Nakai, are listed as source plants of Herba Epimedii in the latest edition of the Chinese Pharmacopoeia.
520 $a In this study, chloroplast DNA sequences of trnL/trnF intergenic spacer, nuclear ribosomal DNA sequences of internal transcribed spacer (ITS) and 5S rRNA gene spacer were explored to characterize the different Epimedium species. A total of 22 Epimedium species were collected and analyzed. DNA sequences of 5S rRNA gene spacer were more varied than that of trnL/trnF intergenic spacer and ITS, thus providing more phylogenetic information. Sequences of 5S rRNA gene spacer were useful to identify and differentiate the five Epimedium species listed in the Chinese Pharmacopoeia.
520 $a Preventive effects of Herba Epimedii (Epimedium wushanense) and formula-ELP against osteopenia were evaluated in 11-month-old OVX rats. Herbal intervention was started from the third day after OVX. Nine weeks after intervention, Herba Epimedii (0.5g/rat/day) and formula-ELP (1g/rat/day), and formula-ELP (2g/rat/day) significantly depressed integral and trabecular BMD decrease at lumbar spine in OVX rats. Nine weeks after intervention, Herba Epimedii (0.5g/rat/day) and formula-ELP (0.5g/rat/day), formula-ELP (1g/rat/day), and formula-ELP (2g/rat/day) significantly depressed integral and trabecular BMD decrease at proximal tibia metaphysis. Significant effect by formula-ELP (2g/rat/day) was showed as early as three weeks after intervention. In groups treated by Herba Epimedii (0.5g/rat/day), formula-ELP (0.5g/rat/day), formula-ELP (1g/rat/day), and formula-ELP (2g/rat/day), urinary deoxypyridinoline/creatinine and serum osteocalcin were significantly lower than that of the OVX control group nine weeks after treatment.{09}In groups treated by Herba Epimedii (0.5g/rat/day), formula-ELP (0.5g/rat/day), and formula-ELP (2g/rat/day), total ALP activities in serum were significantly lower than that of the OVX control group nine weeks after intervention. (Abstract shortened by UMI.)
590 $a School code: 1307.
650 4 $a Biophysics, Medical. $3 1017681
650 4 $a Chemistry, Pharmaceutical. $3 550957
690 $a 0760
690 $a 0491
710 2 0 $a The Chinese University of Hong Kong (People's Republic of China). $3 1265600
773 0 $t Dissertation Abstracts International $g 66-07B.
790 1 0 $a Fung, Kwok-Pui, $e advisor
790 1 0 $a Shaw, Pang-Chui, $e advisor
790 $a 1307
791 $a Ph.D.
792 $a 2005
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3182164